PDIA2
Basic information
Region (hg38): 16:283164-287215
Previous symbols: [ "PDIP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDIA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 70 | 75 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 70 | 11 | 2 |
Variants in PDIA2
This is a list of pathogenic ClinVar variants found in the PDIA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-283176-C-T | not specified | Uncertain significance (Nov 20, 2024) | ||
16-283220-G-A | Likely benign (Sep 01, 2022) | |||
16-283270-C-T | not specified | Uncertain significance (Dec 07, 2024) | ||
16-283315-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
16-283321-C-G | not specified | Uncertain significance (Sep 14, 2022) | ||
16-283351-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
16-284399-G-A | not specified | Uncertain significance (Sep 29, 2022) | ||
16-284446-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
16-284452-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
16-284453-C-T | not specified | Uncertain significance (Jun 23, 2023) | ||
16-284503-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
16-284505-C-T | Likely benign (Jul 01, 2024) | |||
16-284506-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
16-284539-C-G | not specified | Uncertain significance (Aug 14, 2024) | ||
16-284557-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
16-284558-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
16-284570-G-A | Uncertain significance (May 31, 2019) | |||
16-284573-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
16-284575-C-T | not specified | Uncertain significance (Dec 21, 2021) | ||
16-284579-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
16-284581-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
16-284584-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
16-284590-A-G | not specified | Uncertain significance (Oct 05, 2021) | ||
16-284662-C-T | not specified | Uncertain significance (May 09, 2023) | ||
16-284670-G-A | not specified | Uncertain significance (Aug 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDIA2 | protein_coding | protein_coding | ENST00000219406 | 11 | 4064 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.45e-33 | 3.16e-8 | 119718 | 40 | 5017 | 124775 | 0.0205 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.73 | 418 | 330 | 1.27 | 0.0000224 | 3347 |
Missense in Polyphen | 134 | 108.09 | 1.2397 | 1264 | ||
Synonymous | -5.42 | 237 | 152 | 1.56 | 0.0000115 | 1103 |
Loss of Function | -3.30 | 39 | 22.2 | 1.75 | 0.00000102 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0575 | 0.0527 |
Ashkenazi Jewish | 0.0604 | 0.0397 |
East Asian | 0.000841 | 0.000668 |
Finnish | 0.0294 | 0.0263 |
European (Non-Finnish) | 0.0278 | 0.0198 |
Middle Eastern | 0.000841 | 0.000668 |
South Asian | 0.0325 | 0.0235 |
Other | 0.0333 | 0.0249 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an intracellular estrogen-binding protein. May be involved in modulating cellular levels and biological functions of estrogens in the pancreas. May act as a chaperone that inhibits aggregation of misfolded proteins. {ECO:0000269|PubMed:19150607, ECO:0000269|PubMed:19429457}.;
- Pathway
- Ibuprofen Action Pathway;Phenytoin (Antiarrhythmic) Action Pathway;Ibuprofen Metabolism Pathway;Morphine Metabolism Pathway;Irinotecan Action Pathway;Morphine Action Pathway;Etoposide Action Pathway;Sorafenib Metabolism Pathway;Acetaminophen Metabolism Pathway;Vitamin A Deficiency;Irinotecan Metabolism Pathway;Etoposide Metabolism Pathway;Retinol Metabolism;Demo complete;Statin Pathway;Validated nuclear estrogen receptor alpha network
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.974
- rvis_EVS
- 2.7
- rvis_percentile_EVS
- 98.9
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.318
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.572
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdia2
- Phenotype
Gene ontology
- Biological process
- protein folding;protein retention in ER lumen;peptidyl-proline hydroxylation;protein folding in endoplasmic reticulum;response to endoplasmic reticulum stress;cell redox homeostasis;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum lumen
- Molecular function
- steroid binding;protein binding;disulfide oxidoreductase activity;peptide disulfide oxidoreductase activity